John‐Michael Williford

1.5k total citations
11 papers, 1.2k citations indexed

About

John‐Michael Williford is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, John‐Michael Williford has authored 11 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in John‐Michael Williford's work include RNA Interference and Gene Delivery (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Immunotherapy and Immune Responses (4 papers). John‐Michael Williford is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Immunotherapy and Immune Responses (4 papers). John‐Michael Williford collaborates with scholars based in United States, Switzerland and United Kingdom. John‐Michael Williford's co-authors include Hai‐Quan Mao, José Luís Santos, John W. Hickey, Yong Ren, Jun Ishihara, Aslan Mansurov, Peyman Hosseinchi, Jeffrey A. Hubbell, Melody A. Swartz and Ako Ishihara and has published in prestigious journals such as Advanced Materials, Journal of Controlled Release and Small.

In The Last Decade

John‐Michael Williford

11 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John‐Michael Williford United States 10 473 347 342 312 302 11 1.2k
Aaron P. Griset United States 9 498 1.1× 288 0.8× 345 1.0× 384 1.2× 112 0.4× 13 1.3k
Lorena Simón‐Gracia Estonia 19 630 1.3× 322 0.9× 301 0.9× 380 1.2× 172 0.6× 36 1.2k
João Conniot Portugal 15 697 1.5× 588 1.7× 425 1.2× 451 1.4× 216 0.7× 19 1.6k
Suxin Li China 15 619 1.3× 435 1.3× 534 1.6× 284 0.9× 237 0.8× 42 1.4k
Shiran Ferber Israel 16 448 0.9× 416 1.2× 194 0.6× 299 1.0× 180 0.6× 21 1.1k
Brandon Piel United States 8 472 1.0× 415 1.2× 336 1.0× 409 1.3× 287 1.0× 10 1.2k
Elana Ben‐Akiva United States 12 539 1.1× 423 1.2× 194 0.6× 419 1.3× 132 0.4× 25 1.1k
Xinghui Si China 19 386 0.8× 622 1.8× 470 1.4× 346 1.1× 259 0.9× 37 1.2k
Weihang Ji United States 18 638 1.3× 593 1.7× 370 1.1× 478 1.5× 390 1.3× 23 1.5k
Ayelet David Israel 20 613 1.3× 288 0.8× 174 0.5× 413 1.3× 138 0.5× 35 1.1k

Countries citing papers authored by John‐Michael Williford

Since Specialization
Citations

This map shows the geographic impact of John‐Michael Williford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John‐Michael Williford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John‐Michael Williford more than expected).

Fields of papers citing papers by John‐Michael Williford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John‐Michael Williford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John‐Michael Williford. The network helps show where John‐Michael Williford may publish in the future.

Co-authorship network of co-authors of John‐Michael Williford

This figure shows the co-authorship network connecting the top 25 collaborators of John‐Michael Williford. A scholar is included among the top collaborators of John‐Michael Williford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John‐Michael Williford. John‐Michael Williford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mansurov, Aslan, Peyman Hosseinchi, Kevin Chang, et al.. (2022). Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker. Nature Biomedical Engineering. 6(7). 819–829. 63 indexed citations
2.
Mansurov, Aslan, Jun Ishihara, Peyman Hosseinchi, et al.. (2020). Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nature Biomedical Engineering. 4(5). 531–543. 178 indexed citations
3.
Ishihara, Jun, Ako Ishihara, Koichi Sasaki, et al.. (2019). Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Science Translational Medicine. 11(487). 147 indexed citations
4.
Williford, John‐Michael, Jun Ishihara, Ako Ishihara, et al.. (2019). Recruitment of CD103 + dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Science Advances. 5(12). eaay1357–eaay1357. 99 indexed citations
5.
Santos, José Luís, Yong Ren, Maani M. Archang, et al.. (2016). Continuous Production of Discrete Plasmid DNA‐Polycation Nanoparticles Using Flash Nanocomplexation. Small. 12(45). 6214–6222. 71 indexed citations
6.
Santos, José Luís, Yong Ren, Maani M. Archang, et al.. (2016). DNA Nanoparticles: Continuous Production of Discrete Plasmid DNA‐Polycation Nanoparticles Using Flash Nanocomplexation (Small 45/2016). Small. 12(45). 6177–6177. 1 indexed citations
7.
Hickey, John W., José Luís Santos, John‐Michael Williford, & Hai‐Quan Mao. (2015). Control of polymeric nanoparticle size to improve therapeutic delivery. Journal of Controlled Release. 219. 536–547. 294 indexed citations
8.
Williford, John‐Michael, et al.. (2015). Shape control in engineering of polymeric nanoparticles for therapeutic delivery. Biomaterials Science. 3(7). 894–907. 97 indexed citations
9.
Williford, John‐Michael, et al.. (2014). Shape transformation following reduction-sensitive PEG cleavage of polymer/DNA nanoparticles. Journal of Materials Chemistry B. 2(46). 8106–8109. 12 indexed citations
10.
Williford, John‐Michael, Juan Wu, Yong Ren, et al.. (2014). Recent Advances in Nanoparticle-Mediated siRNA Delivery. Annual Review of Biomedical Engineering. 16(1). 347–370. 135 indexed citations
11.
Jiang, Xuan, Wei Qu, Deng Pan, et al.. (2012). Plasmid‐Templated Shape Control of Condensed DNA–Block Copolymer Nanoparticles. Advanced Materials. 25(2). 227–232. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron P. Griset Breakdown of academic impact, for papers by Lorena Simón‐Gracia Breakdown of academic impact, for papers by João Conniot Breakdown of academic impact, for papers by Suxin Li Breakdown of academic impact, for papers by Shiran Ferber Breakdown of academic impact, for papers by Brandon Piel Breakdown of academic impact, for papers by Elana Ben‐Akiva Breakdown of academic impact, for papers by Xinghui Si Breakdown of academic impact, for papers by Weihang Ji Breakdown of academic impact, for papers by Ayelet David
Rankless by CCL
2026